Pharmacovigilance is the practice area aimed at ensuring drug safety through in-depth data collection and evaluation. As part of
Evaluating 22 pharmacovigilance and complaint management BPS providers, Cognizant's honor was fueled by the company's immense scale of operations, strong domain expertise and overall market presence - with Cognizant increasing its revenue portfolio year-over-year. This success comes as Cognizant continues to invest in strengthening its technology-enabled solutions to better help clients achieve their digital transformation goals. Cognizant is also committed to creating a global network of delivery operations centers, which provides customized support for clients and an additional layer of business continuity.
Continue Reading
[Cognizant - Services Peak Matrix Assessment 2021]
Cognizant - Services Peak Matrix Assessment 2021
'There is a widespread consensus in the drug/device vigilance market that significantly increasing safety case processing volumes is one of the most pressing challenges for enterprises,' said
'Following the unanticipated impact of the COVID-19 global pandemic, we expect to see continuity in vaccine development and novel drug therapies over the next several years,' said
View an extract of the Everest Group PEAK Matrix Report
Learn more about Cognizant Life Sciences Technology Solutions
About Cognizant
Cognizant (Nasdaq-100: CTSH) is one of the world's leading professional services companies, transforming clients' business, operating, and technology models for the digital era. Our unique industry-based, consultative approach helps clients envision, build and run more innovative and efficient businesses. Headquartered in the
For further information, contact:
US:
joshua.blumenthal@cognizant.com
Christina.Schneider@cognizant.com
Asia-Pac:
harsh.kabra@cognizant.com
(C) 2021 Electronic News Publishing, source